ANXA5 and glioblastoma: We discovered that this ROS-inducing combination treatment sensitized the GBM cells for caspase-3/7-dependent apoptosis, based on an increase of caspase-3/7- and Annexin V-positive cells, as well as ferroptosis, due to lipid peroxidation and cell death inhibition by an iron chelating agent, DFO.